Symposia: Lymphocytes and Acquired or Congenital Immunodeficiency Disorders
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, autoimmune disorders, Lymphoid Leukemias, Fundamental Science, clinical trials, Lymphomas, Translational Research, epidemiology, autoimmune hemolytic anemia, Genetic Disorders, LGL, B Cell lymphoma, Clinical Research, health outcomes research, drug development, Diseases, Immune Disorders, immunodeficiency, Therapies, immunology, neutropenia, Lymphoid Malignancies, Biological Processes, molecular biology, pathogenesis
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, autoimmune disorders, Lymphoid Leukemias, Fundamental Science, clinical trials, Lymphomas, Translational Research, epidemiology, autoimmune hemolytic anemia, Genetic Disorders, LGL, B Cell lymphoma, Clinical Research, health outcomes research, drug development, Diseases, Immune Disorders, immunodeficiency, Therapies, immunology, neutropenia, Lymphoid Malignancies, Biological Processes, molecular biology, pathogenesis
Monday, December 12, 2022: 10:30 AM-12:00 PM
278-282
(Ernest N. Morial Convention Center)
Moderators:
Jennifer N. Saultz, DO, The Ohio State University
and
Roshini S. Abraham, PhD, Nationwide Childrens Hospital
Disclosures:
Abraham: Beckman Coulter: Honoraria; Enzyvant: Consultancy, Honoraria.
This symposium will highlight cutting-edge pre-clinical and clinical studies aimed at increasing our understanding of lymphocytes and their contribution to the pathophysiology of acquired or congenital immunodeficiency disorders.
10:30 AM
10:45 AM
11:00 AM
11:30 AM
11:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH